INSR and fatty liver disease: One explanation is that, while patients homozygous for INSR LOF variants present with severe insulin resistance [65], those heterozygous are generally asymptomatic, and heterozygous impairment of INSR expression protects from and reverses diet-induced hepatic steatosis in mice [66].